Neogen Chemicals

Download IPO Forms (Pre filled Forms): CLICK HERE

IPO Details:

Issue Open Date April 24, 2019 Price Band : Rs. 212 – Rs. 215
Issue Open Date April 26, 2019 Minimum Bid Qty : 65 Equity Shares and in multiples thereof
Face Value Rs. 10 Minimum Investment : Rs. 13975/-



Incorporated in 1991, Neogen Chemicals is Mahape, Navi Mumbai based manufacturer of bromine-based and lithium-based specialty chemicals in India. Neogen makes both organic and inorganic chemical compounds.


These specialty chemicals are used in pharmaceutical intermediates, agrochemical intermediates, engineering fluids, electronic chemicals, polymers additives, water treatment chemicals, construction chemicals, and flavors and fragrances.


As on February 28, 2019, we have manufactured an aggregate of 198 products comprising 181 organic chemicals and 17 inorganic chemicals. The company markets and sells products in India, Europe, Japan, and the USA.


The manufacturing units of the company are located in Navi Mumbai in Maharashtra and Karakhadi, Vadodara in Gujarat. Neogen is proposing to expand its manufacturing facilities by setting up new units at Vadodara Facility and the Dahej Facility. The Proposed Dahej Facility is a green-field manufacturing facility for manufacturing inorganic chemical products.


The company annually manufactures 1,30,400 liters of organic chemicals and 1,200,000 Kg. of inorganic chemicals.

Company Promoters :

  1. Haridas Thakarshi Kanani
  2. Harin Haridas Kanani

Neogen Chemicals Limited IPO Registrar:

Name of the Registrar : Link Intime India Private Limited

Address of the Registrar : C-101, 1st Floor, 247 Park, L.B.S. Marg, Vikhroli (West), 400 083, Mumbai, Maharashtra, India

Contact person name  :  Shanti Gopalkrishnan

Contact details+91 22 4918 6200

Email ID :


Note: Check Neogen Chemicals Limited IPO allotment status on Linkintime website allotment url. Click Here


Download IPO Forms (Pre filled Forms) :  CLICK HERE


Note : You can contact Mr. Bhavesh on 079-68174005 , for any help regarding IPO subcription